Browse

Trump's embrace of psychedelics and cannabis is shaking up the GOP’s relationship with mind-altering substances.

What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts has some answers.

A Utah pilot to renew prescriptions using a bot faced backlash from the state's medical board, which called for an immediate suspension.